Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Moderna

Moderna seeks volunteers for Omicron booster vaccine study

UK volunteers needed to take part in trials

Wales Online

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

The Conversation

Moderna Continues To See Bearish Movement: What's Next For The COVID-19 Stock?

Moderna Inc. (NASDAQ: MRNA) shares are trading lower Monday.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna CEO Sells Shares, Deletes Social Media: What You Need To Know

Moderna Inc (NASDAQ: MRNA) shares are down more than 40% since the start of the year and continue to trend lower Monday.

Benzinga

Coronavirus live: UK records 41,648 new cases and 35 Covid-linked deaths; French protest convoy reaches Brussels – as it happened

UK cases down 30% on the previous week, with weekly deaths down 27.2%; 500 French vehicles arrive in Brussels to protest against Covid measures

The Guardian - AU

How effective are the Pfizer, AstraZeneca and Moderna vaccines against Omicron?

Booster jabs provide up to 70 per cent protection, study finds

The Independent UK

We’ve Officially Got A Fourth Vaccine, So Here’s Everything You Need To Know About Novavax

Say hello to Ms Novavax!

Pedestrian.tv

Read news from The Economist, FT, and more,
with one subscription

Hawaii, New York enact new congressional district maps; Pennsylvania Supreme Court assumes control over redistricting

Our weekly summary of federal news highlights redistricting updates in Hawaii, New York, and Pennsylvania, and the FDA approving the Moderna COVID-19 vaccine. Read all about it in this week’s edition of the Federal Tap.

Ballotpedia

Moderna’s COVID-19 vaccine gets backing from CDC advisory panel

Moderna Inc.’s COVID-19 shot received unanimous backing from a group of key U.S. health advisers after its approval, a move that could help encourage the hesitant to get vaccinated as the omicron variant continues to spread across the country.

Tribune News Service

At last, HIV vaccine in phase one trials

Years of false starts have made hopeful researchers wary of claims that an HIV vaccine is finally here

Salon

Turkey reports daily record of 111,157 new cases – as it happened

Turkish daily death toll highest in four months as cases surge; UK health agency says number of cases each day could be rising

The Guardian - AU

Coronavirus live: Europe in virus ‘ceasefire’ with tranquil period ahead, says WHO; record UK long Covid cases — as it happened

Europe could enter ‘long period of Covid tranquility’ due to high vaccination rates, WHO says; record 1.33 million UK long Covid patients

The Guardian - AU

Covid rules on travelling to different countries around Europe

Here's everything you need to know about vaccination status and testing process in countries such as France, Austria, Switzerland and Italy

Wales Online

Moderna Whale Trades For February 02

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 10 strange trades.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

Study confirms effectiveness of COVID-19 booster vaccinations

A new study from the Center for Disease Control and Prevention confirms what Mayo Clinic and other experts have been saying: COVID-19 booster vaccinations improve protection against severe illness and hospitalization. The study examined people who had three doses of the Moderna or Pfizer COVID-19 vaccines, as well as whether…

Tribune News Service

Moderna gains full FDA approval for COVID-19 vaccine while Novavax makes push for its own shot

WASHINGTON — Moderna Inc.’s vaccine for COVID-19 received full approval from the U.S. Food and Drug Administration for people 18 and older, an important milestone that bolsters the shot’s use as a major weapon against the virus.

Benzinga

Why Moderna Shares Are Rising Today

Moderna Inc (NASDAQ: MRNA) is trading higher Monday after the U.S. Food and Drug Administration approved the Biologics License Application for SPIKEVAX to prevent COVID-19 in individuals 18 years of age and older.

Benzinga

Moderna's COVID-19 Vaccine Becomes Second To Score Complete FDA Approval

The FDA has given complete approval to Moderna Inc's (NASDAQ:

Get all your
news in one place.

100's of premium titles.
One news app.

Axios

FDA fully approves Moderna's COVID vaccine

Moderna's vaccine will now be marketed as Spikevax.

The Independent UK

Moderna announces full US approval for its COVID-19 vaccine

Moderna says U.S. health regulators have given full approval to its COVID-19 vaccine after reviewing additional data on its safety and effectiveness

Benzinga

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

The Guardian - AU

Covid news: UK health secretary says mandatory vaccination for NHS workers ‘no longer proportionate’ – as it happened

Sajid Javid says says mandatory jabs were ‘right policy at the time’ but announces review

Mic

An HIV vaccine is finally on its way

The same mRNA technology that’s helping us fight COVID provided a formula that’s evaded scientists for 40 years.

Benzinga

The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

After Pfizer, Moderna Kickstarts Omicron-Targeted COVID-19 Vaccine Trial

Moderna Inc (NASDAQ: MRNA) has started a mid-stage study, testing a booster dose of its COVID-19 vaccine specifically

1 … 31 32 33 34

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.